| striated muscle contraction | GO:0006941 | 45 | 0.948 | |
| muscle cell development | GO:0055001 | 133 | 0.942 | |
| muscle system process | GO:0003012 | 141 | 0.923 | |
| calcium ion transport from endoplasmic reticulum to cytosol | GO:1903514 | 12 | 0.912 | |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0010880 | 10 | 0.905 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.893 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.826 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.800 | |
| heart contraction | GO:0060047 | 93 | 0.796 | |
| myofibril assembly | GO:0030239 | 34 | 0.793 | |
| circulatory system process | GO:0003013 | 197 | 0.790 | |
| striated muscle cell development | GO:0055002 | 125 | 0.783 | |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | GO:0010881 | 7 | 0.768 | |
| muscle tissue development | GO:0060537 | 308 | 0.741 | |
| regulation of ryanodine sensitive calcium release channel activity | GO:0060314 | 10 | 0.741 | |
| blood circulation | GO:0008015 | 195 | 0.732 | |
| sarcomere organization | GO:0045214 | 24 | 0.731 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.718 | |
| muscle contraction | GO:0006936 | 101 | 0.710 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.703 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.695 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.682 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.669 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.668 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.657 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.643 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.631 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.624 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.614 | |
| regulation of system process | GO:0044057 | 200 | 0.609 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.606 | |
| transmembrane transport | GO:0055085 | 412 | 0.603 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.585 | |
| muscle fiber development | GO:0048747 | 76 | 0.558 | |
| organelle assembly | GO:0070925 | 177 | 0.552 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.551 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.520 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.463 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.437 | |
| cation transport | GO:0006812 | 399 | 0.436 | |
| vasoconstriction | GO:0042310 | 27 | 0.430 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.428 | |
| regulation of ion transport | GO:0043269 | 215 | 0.407 | |
| heart process | GO:0003015 | 94 | 0.407 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.396 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.387 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.385 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.385 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.380 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.376 | |
| amine metabolic process | GO:0009308 | 45 | 0.364 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.362 | |
| cardiac cell development | GO:0055006 | 41 | 0.361 | |
| forward locomotion | GO:0043056 | 1 | 0.344 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.337 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.332 | |
| relaxation of muscle | GO:0090075 | 18 | 0.323 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.322 | |
| acetylcholine transport | GO:0015870 | 2 | 0.311 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.307 | |
| regulation of sodium ion transmembrane transport | GO:1902305 | 9 | 0.298 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.296 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.295 | |
| cation homeostasis | GO:0055080 | 212 | 0.295 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.280 | |
| myotube differentiation | GO:0014902 | 105 | 0.269 | |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 4 | 0.261 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.260 | |
| regulation of sodium ion transmembrane transporter activity | GO:2000649 | 9 | 0.257 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.255 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.252 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.251 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.246 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.246 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.242 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.237 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.236 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.223 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.222 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.219 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.216 | |
| cellular homeostasis | GO:0019725 | 240 | 0.216 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.213 | |
| action potential | GO:0001508 | 78 | 0.212 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.202 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.202 | |
| vascular smooth muscle cell differentiation | GO:0035886 | 11 | 0.201 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.194 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.192 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.173 | |
| directional locomotion | GO:0033058 | 3 | 0.172 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.169 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.168 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.168 | |
| myotube cell development | GO:0014904 | 60 | 0.167 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.166 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.166 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.165 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.163 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.160 | |
| release of sequestered calcium ion into cytosol | GO:0051209 | 42 | 0.159 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.156 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.154 | |
| heart trabecula formation | GO:0060347 | 14 | 0.152 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.149 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.139 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.139 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.138 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.138 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.133 | |
| calcium ion transport | GO:0006816 | 159 | 0.131 | |
| maintenance of location | GO:0051235 | 89 | 0.131 | |
| circadian sleep wake cycle rem sleep | GO:0042747 | 1 | 0.129 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.128 | |
| organelle fission | GO:0048285 | 170 | 0.126 | |
| response to inactivity | GO:0014854 | 4 | 0.125 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.117 | |
| heart morphogenesis | GO:0003007 | 178 | 0.115 | |
| glycosylation | GO:0070085 | 62 | 0.115 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.113 | |
| acetate ester transport | GO:1901374 | 2 | 0.109 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.108 | |
| positive regulation of blood circulation | GO:1903524 | 22 | 0.108 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.106 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.106 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.105 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.104 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.103 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.101 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.098 | |
| synaptic transmission involved in micturition | GO:0060084 | 3 | 0.097 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.095 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.095 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.095 | |
| cellular modified amino acid biosynthetic process | GO:0042398 | 12 | 0.094 | |
| response to muscle inactivity involved in regulation of muscle adaptation | GO:0014877 | 4 | 0.094 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.091 | |
| regulation of tube size | GO:0035150 | 57 | 0.091 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.091 | |
| negative regulation of ion transport | GO:0043271 | 28 | 0.090 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.089 | |
| mapk cascade | GO:0000165 | 281 | 0.088 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.085 | |
| potassium ion transport | GO:0006813 | 52 | 0.085 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.081 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.080 | |
| muscle cell cellular homeostasis | GO:0046716 | 12 | 0.079 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.079 | |
| cardiac chamber development | GO:0003205 | 108 | 0.076 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.075 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.074 | |
| microtubule based process | GO:0007017 | 236 | 0.074 | |
| positive regulation of sodium ion transport | GO:0010765 | 13 | 0.072 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.072 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.071 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.070 | |
| positive regulation of dopamine secretion | GO:0033603 | 2 | 0.070 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.070 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.067 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.066 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.066 | |
| membrane organization | GO:0061024 | 245 | 0.065 | |
| lipid localization | GO:0010876 | 126 | 0.064 | |
| negative regulation of transmembrane transport | GO:0034763 | 15 | 0.063 | |
| regulation of circadian sleep wake cycle rem sleep | GO:0042320 | 1 | 0.063 | |
| regulation of relaxation of muscle | GO:1901077 | 8 | 0.063 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.062 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.062 | |
| protein localization to organelle | GO:0033365 | 185 | 0.061 | |
| positive regulation of sodium ion transmembrane transporter activity | GO:2000651 | 3 | 0.060 | |
| actin filament organization | GO:0007015 | 113 | 0.060 | |
| protein glycosylation | GO:0006486 | 55 | 0.059 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.059 | |
| norepinephrine transport | GO:0015874 | 2 | 0.058 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.058 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.058 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.058 | |
| baroreceptor response to decreased systemic arterial blood pressure | GO:0001982 | 2 | 0.058 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.057 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.056 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.056 | |
| protein ubiquitination | GO:0016567 | 171 | 0.055 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.055 | |
| membrane depolarization | GO:0051899 | 64 | 0.055 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.055 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.055 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.055 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.053 | |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.053 | |
| sodium ion transport | GO:0006814 | 73 | 0.052 | |
| lipid homeostasis | GO:0055088 | 63 | 0.051 | |
| defecation | GO:0030421 | 1 | 0.050 | |
| rhythmic process | GO:0048511 | 174 | 0.050 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.050 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.049 | |
| cardiac muscle cell action potential | GO:0086001 | 11 | 0.049 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.049 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.049 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 3 | 0.049 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.049 | |
| positive regulation of metalloenzyme activity | GO:0048554 | 3 | 0.049 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.048 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.048 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.048 | |
| sensory perception | GO:0007600 | 245 | 0.048 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.047 | |
| peptidyl cysteine modification | GO:0018198 | 8 | 0.047 | |
| adult behavior | GO:0030534 | 135 | 0.046 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.046 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.045 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.045 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.045 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.045 | |
| fertilization | GO:0009566 | 127 | 0.045 | |
| gas homeostasis | GO:0033483 | 3 | 0.045 | |
| glucose homeostasis | GO:0042593 | 128 | 0.044 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.044 | |
| glial cell development | GO:0021782 | 54 | 0.044 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.044 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.043 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.043 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.043 | |
| response to ischemia | GO:0002931 | 14 | 0.043 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.043 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.043 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.043 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.042 | |
| neuronal action potential | GO:0019228 | 54 | 0.042 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.042 | |
| lipid transport | GO:0006869 | 98 | 0.042 | |
| regulation of smooth muscle contraction | GO:0006940 | 22 | 0.041 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.041 | |
| regulation of cation channel activity | GO:2001257 | 22 | 0.041 | |
| response to inorganic substance | GO:0010035 | 96 | 0.041 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.041 | |
| response to metal ion | GO:0010038 | 47 | 0.040 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.040 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.039 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.039 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.039 | |
| myosin filament assembly | GO:0031034 | 2 | 0.038 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.038 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.038 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.038 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.038 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.037 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.037 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.037 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.037 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.036 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.036 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.035 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.035 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.035 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.034 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.034 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.034 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.033 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.033 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.033 | |
| sterol homeostasis | GO:0055092 | 45 | 0.033 | |
| actin filament based movement | GO:0030048 | 23 | 0.033 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.033 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.033 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.033 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.032 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.032 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.032 | |
| regulation of atpase activity | GO:0043462 | 9 | 0.032 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.032 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.031 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.031 | |
| axon ensheathment | GO:0008366 | 76 | 0.031 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.031 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.031 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.031 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.031 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.031 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.030 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.030 | |
| response to hypoxia | GO:0001666 | 58 | 0.029 | |
| regulation of skeletal muscle contraction by calcium ion signaling | GO:0014722 | 3 | 0.029 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.029 | |
| mitochondrion degradation | GO:0000422 | 3 | 0.029 | |
| rna processing | GO:0006396 | 105 | 0.029 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.029 | |
| synaptic transmission | GO:0007268 | 329 | 0.029 | |
| spermatogenesis | GO:0007283 | 284 | 0.029 | |
| regulation of heart rate | GO:0002027 | 36 | 0.029 | |
| circadian rhythm | GO:0007623 | 114 | 0.029 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.028 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.028 | |
| membrane repolarization | GO:0086009 | 7 | 0.028 | |
| muscle adaptation | GO:0043500 | 39 | 0.028 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.028 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.028 | |
| nuclear division | GO:0000280 | 158 | 0.028 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.028 | |
| positive regulation of catecholamine secretion | GO:0033605 | 2 | 0.028 | |
| adaptive immune response | GO:0002250 | 155 | 0.027 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.027 | |
| response to muscle stretch | GO:0035994 | 1 | 0.027 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.027 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.027 | |
| negative regulation of endothelial cell proliferation | GO:0001937 | 8 | 0.027 | |
| angiogenesis | GO:0001525 | 201 | 0.027 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.027 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.027 | |
| glial cell differentiation | GO:0010001 | 131 | 0.027 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.026 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.026 | |
| response to growth factor | GO:0070848 | 198 | 0.026 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.026 | |
| response to calcium ion | GO:0051592 | 20 | 0.026 | |
| spermatid differentiation | GO:0048515 | 115 | 0.026 | |
| gland development | GO:0048732 | 330 | 0.026 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.026 | |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.025 | |
| regulation of protein stability | GO:0031647 | 52 | 0.025 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.025 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.025 | |
| positive regulation of myotube differentiation | GO:0010831 | 24 | 0.025 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.025 | |
| protein localization to cell junction | GO:1902414 | 3 | 0.025 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.025 | |
| myosin filament organization | GO:0031033 | 3 | 0.025 | |
| epithelial cell development | GO:0002064 | 159 | 0.025 | |
| negative regulation of peptidyl tyrosine phosphorylation | GO:0050732 | 17 | 0.025 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.025 | |
| dephosphorylation | GO:0016311 | 129 | 0.025 | |
| cell adhesion | GO:0007155 | 329 | 0.025 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.025 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.024 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.024 | |
| negative regulation of tyrosine phosphorylation of stat5 protein | GO:0042524 | 2 | 0.024 | |
| cranial nerve morphogenesis | GO:0021602 | 26 | 0.024 | |
| response to oxygen levels | GO:0070482 | 62 | 0.024 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.024 | |
| septum transversum development | GO:0003343 | 2 | 0.024 | |
| mitochondrion organization | GO:0007005 | 134 | 0.024 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.024 | |
| response to steroid hormone | GO:0048545 | 56 | 0.024 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.024 | |
| response to radiation | GO:0009314 | 165 | 0.024 | |
| protein targeting | GO:0006605 | 143 | 0.024 | |
| protein localization to membrane | GO:0072657 | 108 | 0.024 | |
| positive regulation of atpase activity | GO:0032781 | 3 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.024 | |
| associative learning | GO:0008306 | 61 | 0.023 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.023 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.023 | |
| plasma membrane repair | GO:0001778 | 7 | 0.023 | |
| sperm motility | GO:0030317 | 47 | 0.023 | |
| organic anion transport | GO:0015711 | 137 | 0.023 | |
| jak stat cascade | GO:0007259 | 42 | 0.023 | |
| striated muscle hypertrophy | GO:0014897 | 24 | 0.023 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.023 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.023 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.023 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.023 | |
| proepicardium development | GO:0003342 | 2 | 0.023 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.023 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.023 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.023 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.023 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.022 | |
| visual behavior | GO:0007632 | 45 | 0.022 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.022 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.022 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.022 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.022 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.022 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.022 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.022 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.022 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.022 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.022 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.022 | |
| response to light stimulus | GO:0009416 | 135 | 0.021 | |
| regulation of synaptic activity | GO:0060025 | 1 | 0.021 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.021 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.021 | |
| rna interference | GO:0016246 | 2 | 0.021 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.021 | |
| single organism nuclear import | GO:1902593 | 95 | 0.021 | |
| translation | GO:0006412 | 93 | 0.021 | |
| positive regulation of transporter activity | GO:0032411 | 17 | 0.021 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.021 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.021 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.021 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.021 | |
| lateral geniculate nucleus development | GO:0021771 | 1 | 0.021 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.020 | |
| protein catabolic process | GO:0030163 | 221 | 0.020 | |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.020 | |
| protein palmitoylation | GO:0018345 | 14 | 0.020 | |
| response to denervation involved in regulation of muscle adaptation | GO:0014894 | 4 | 0.020 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.020 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.020 | |
| regulation of metalloenzyme activity | GO:0048552 | 4 | 0.020 | |
| plasma membrane organization | GO:0007009 | 90 | 0.020 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.020 | |
| somite development | GO:0061053 | 81 | 0.020 | |
| spermatid development | GO:0007286 | 108 | 0.020 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.020 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.020 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.020 | |
| regulation of potassium ion transport | GO:0043266 | 16 | 0.020 | |
| oxidation reduction process | GO:0055114 | 342 | 0.020 | |
| eosinophil migration | GO:0072677 | 3 | 0.019 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.019 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.019 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.019 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.019 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.019 | |
| cytokinetic process | GO:0032506 | 2 | 0.019 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.019 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.019 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.019 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.019 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.019 | |
| synapse organization | GO:0050808 | 125 | 0.019 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.019 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.019 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.019 | |
| lipid storage | GO:0019915 | 36 | 0.019 | |
| organelle localization | GO:0051640 | 179 | 0.018 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.018 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.018 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.018 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.018 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.018 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.018 | |
| his purkinje system development | GO:0003164 | 4 | 0.018 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.018 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.018 | |
| mrna metabolic process | GO:0016071 | 84 | 0.018 | |
| positive regulation of heart contraction | GO:0045823 | 14 | 0.018 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.018 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.018 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.018 | |
| response to nutrient levels | GO:0031667 | 109 | 0.018 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.018 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.018 | |
| mating behavior sex discrimination | GO:0048047 | 1 | 0.018 | |
| disruption of cells of other organism involved in symbiotic interaction | GO:0051818 | 13 | 0.018 | |
| sa node cell action potential | GO:0086015 | 4 | 0.018 | |
| mrna processing | GO:0006397 | 63 | 0.018 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.018 | |
| sinoatrial node cell development | GO:0060931 | 3 | 0.018 | |
| regulation of response to cytokine stimulus | GO:0060759 | 23 | 0.018 | |
| tyrosine phosphorylation of stat5 protein | GO:0042506 | 9 | 0.018 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.018 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.018 | |
| learning or memory | GO:0007611 | 148 | 0.018 | |
| negative regulation of transporter activity | GO:0032410 | 7 | 0.018 | |
| atp metabolic process | GO:0046034 | 75 | 0.018 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.018 | |
| multi organism behavior | GO:0051705 | 62 | 0.017 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.017 | |
| hydrogen transport | GO:0006818 | 35 | 0.017 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.017 | |
| adult walking behavior | GO:0007628 | 41 | 0.017 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.017 | |
| sensory perception of sound | GO:0007605 | 97 | 0.017 | |
| catecholamine secretion | GO:0050432 | 15 | 0.017 | |
| response to copper ion | GO:0046688 | 3 | 0.017 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.017 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.017 | |
| multicellular organismal movement | GO:0050879 | 16 | 0.017 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.017 | |
| muscle hypertrophy | GO:0014896 | 24 | 0.017 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.017 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.017 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.017 | |
| endocytosis | GO:0006897 | 168 | 0.017 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.017 | |
| relaxation of cardiac muscle | GO:0055119 | 9 | 0.017 | |
| regulation of secretion | GO:0051046 | 274 | 0.017 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.017 | |
